Justin Briggs
InvestorPartner at Prime Movers Lab · Founder at Zafrens · Board director at Morphoceuticals · Board director at Lygenesis
Oklahoma City, Oklahoma
Writes $2M – $30M checks · typically $5M
About
Scientific entrepreneur and operator with 15 years of experience in biotech, nanotech, robotics, and software companies. Specializes in therapeutics and regenerative medicines development across multiple disease areas.
Contact· published on Justin's own website
Founder at Zafrens
Intro paths
→
In turn, Justin can intro founders to Zafrens's investors below.
Zafrens's investors · 9
Acequia Capital (AceCap)Seattle · $100K – $5M checks · since 2021BlueYard CapitalBerlin · $500K – $5M checks · since 2021FoundersX VenturesSilicon Valley · since 2021Global BrainTokyo · $100K – $184M checks · since 2021HAWKTAILSan FranciscoIaso VenturesCambridge · since 2021imec.xpandLeuven · $270K – $5.4M checks · since 2021Prime Movers LabJackson · $2M – $30M checks · since 2021Raptor GroupMiami Beach · since 2021
Co-founders at Zafrens
MN
Maina Ndungu
Board director at Morphoceuticals
Intro paths
→
In turn, Justin can intro founders to Morphoceuticals's investors below.
Morphoceuticals's investors · 1
Board director at Lygenesis
Intro paths
→
In turn, Justin can intro founders to Lygenesis's investors below.
Lygenesis's investors · 1
Co-founders at Lygenesis
EL
Eric LagasseExecutive Officer, Director
MH
Michael HuffordExecutive Officer, Director, Promoter
PF
Paulo FontesExecutive Officer, Promoter
EL
Eric LegasseExecutive Officer, Promoter
Experience
- Tulsa Local Ventures + George Kaiser Family FoundationStrategic Advisorcurrent2025 — presentTulsa, Oklahoma, United States
- Prime Movers LabOperating Partnercurrent2024 — presentUnited States
- Prime Movers LabPartner2022 — 2024Pale Blue Dot
- Prime Movers LabVenture Partner2022Pale Blue Dot
- BioeutecticsBoard Membercurrent2025 — presentTulsa, Oklahoma, United States
- ByBugBoard Membercurrent2025 — presentTulsa, Oklahoma, United States
- CASSIE, Inc.Board Membercurrent2025 — presentTulsa, Oklahoma, United States
- VoltBoard Observercurrent2025 — presentTulsa, Oklahoma, United States
- LyGenesisBoard Membercurrent2023 — presentPittsburgh, Pennsylvania, United States
- Morphoceuticals, Inc.Board Membercurrent2023 — presentMedford, Massachusetts, United States
- Iridia, Inc.Board Membercurrent2023 — presentSan Diego, California, United States
- ZafrensVP Corporate Development2024 — 2025San Diego, California, United States
- ZafrensBoard Member2023 — 2024San Diego, California, United States
- Atento CapitalVenture Partner2022 — 2024Tulsa, OK
- Gilgamesh PharmaceuticalsBoard Member2023 — 2024New York, New York, United States
- IVIVA Medical IncBoard Member2023 — 2024Boston, Massachusetts, United States
- Dimension InxBoard Observer2023 — 2024
- Elevian, Inc.Board Member2022 — 2024Boston, Massachusetts, United States
- AntiversePortfolio Director2022United Kingdom
- AntiverseAdvisor2021 — 2022United Kingdom
- TomorrowScale VenturesGeneral Partner2021 — 2022United States
- TomorrowScaleFounder & Host2019 — 2022United States
- Tetherex PharmaceuticalsSenior Director, Drug Development2018 — 2022Oklahoma City, Oklahoma
- Deep Science VenturesVenture Partner2021Global
- BriggsBioPrincipal2017 — 2021Oklahoma City, Oklahoma Area
- SnapLab TechnologiesFounder, Inventor2014 — 2018Oklahoma City, OK
- Accele Biopharma, Inc.Vice President, Business Development & Operations2014 — 2017Oklahoma City, Oklahoma Area
- Chorus LabsFounder, CEO2012 — 2015Oklahoma City, OK
- Altheus Therapeutics, Inc.Corporate Development and Operations2007 — 2014
- Oklahoma Bioscience RoundTableChairman2013
- Center for the Creation of Economic WealthAlumni Team Leader2007Norman, OK
Skills & more
Clinical Development37Entrepreneurship64Commercialization72Regulatory Affairs15Management11Finance2Pharmaceutical Industry20Business Development12Lifesciences14Biotechnology86Start-ups24Strategic Planning13
+12 more
LicensingResearchBiochemistryTechnology TransferIntellectual PropertyDrug DevelopmentData AnalysisVenture CapitalLeadershipStrategyBiopharmaceuticalsClinical Trials- Regulatory Affairs Certification (RAC)
From Justin's professional profile.
Colleagues at Prime Movers Lab
Aaron Mandell
Venture Partner at Prime Movers Lab
Amy Kruse
Venture Partner at Prime Movers Lab
Andre Jabban
Partner and Head of Capital Formation at Prime Movers Lab
Andrei Iancu
Venture Partner at Prime Movers Lab
Bill Gross
Venture Partner at Prime Movers Lab
Blake Scholl
Venture Partner at Prime Movers Lab
Brandon Simmons
General Partner at Prime Movers Lab
Brantley Sydnor
Operations Manager at Prime Movers Lab
Frequently asked questions
- Who is Justin Briggs?
- Scientific entrepreneur and operator with 15 years of experience in biotech, nanotech, robotics, and software companies. Specializes in therapeutics and regenerative medicines development across multiple disease areas.
- Where does Justin Briggs work?
- Justin Briggs is Partner at Prime Movers Lab and Board director at Morphoceuticals and Board director at Lygenesis.
- What check size does Justin Briggs write?
- Justin Briggs typically writes checks of $2M – $30M.
- Where did Justin Briggs go to school?
- Justin Briggs studied at University of Oklahoma (Bachelor of Science (B.Sc.), Biomedical Sciences); Oklahoma City University (MBA, Business Administration).
Same school
Also attended University of Oklahoma77
Tianlin WangManaging Director at Intel CapitalNathan PingeltonManaging Director at Marlin Equity PartnersMichelle GonzalezCorporate Vice President and Global Head of M12Nathaniel HardingManaging Partner at Cortado VenturesMike MoradiGeneral Partner at Cortado VenturesSusan MoringGeneral Partner at Cortado Ventures
+ 71 more
